Overview
Orofacial clefting syndrome (Orphanet code 139039) is a broad grouping term that encompasses a heterogeneous collection of genetic conditions characterized by clefts affecting the oral and facial structures. These clefts may include cleft lip (with or without cleft palate) and isolated cleft palate, occurring either as isolated anomalies or as part of a broader syndromic presentation. Orofacial clefts arise from incomplete fusion of facial structures during early embryonic development, typically between the 4th and 12th weeks of gestation. The condition is apparent at birth and affects the craniofacial system, with potential secondary impacts on feeding, speech, hearing, dental development, and psychosocial well-being. The clinical presentation varies widely depending on the specific underlying genetic cause and whether the clefting occurs in isolation or as part of a recognized syndrome. Isolated (non-syndromic) orofacial clefts are among the most common congenital anomalies worldwide, while syndromic forms may involve additional features such as limb anomalies, cardiac defects, intellectual disability, or other organ system involvement. The genetic basis is highly heterogeneous, with numerous genes implicated including IRF6, MSX1, TBX22, PVRL1, and others, and inheritance patterns vary from autosomal dominant to autosomal recessive, X-linked, or multifactorial depending on the specific subtype. Treatment is multidisciplinary and typically involves surgical repair of the cleft, often beginning in infancy. Cleft lip repair is usually performed around 3 months of age, and cleft palate repair around 9–12 months. Ongoing care may include speech therapy, orthodontic treatment, audiological monitoring, and additional surgical procedures such as alveolar bone grafting or orthognathic surgery as the child grows. Genetic counseling is recommended for affected families to determine the specific subtype, recurrence risk, and any associated syndromic features. With comprehensive care, outcomes for individuals with orofacial clefting have improved significantly.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Orofacial clefting syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Orofacial clefting syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Orofacial clefting syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Orofacial clefting syndrome.
Community
No community posts yet. Be the first to share your experience with Orofacial clefting syndrome.
Start the conversation →Latest news about Orofacial clefting syndrome
No recent news articles for Orofacial clefting syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Orofacial clefting syndrome
What is Orofacial clefting syndrome?
Orofacial clefting syndrome (Orphanet code 139039) is a broad grouping term that encompasses a heterogeneous collection of genetic conditions characterized by clefts affecting the oral and facial structures. These clefts may include cleft lip (with or without cleft palate) and isolated cleft palate, occurring either as isolated anomalies or as part of a broader syndromic presentation. Orofacial clefts arise from incomplete fusion of facial structures during early embryonic development, typically between the 4th and 12th weeks of gestation. The condition is apparent at birth and affects the cra
At what age does Orofacial clefting syndrome typically begin?
Typical onset of Orofacial clefting syndrome is neonatal. Age of onset can vary across affected individuals.